Atrial arrhythmias after lung and heartlung transplant: Effects on short-term mortality and the influence of amiodarone

Journal of Heart and Lung Transplantation

Volumn 30, Issue 1, 2011, Pages 37-44

  Isiadinso, Ijeoma ^a   Meshkov, Arnold B ^a   Gaughan, John ^a   Sandhu, Paul ^a   Lim, Sharon ^a   Cordova, Francis ^a   Criner, Gerard ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amiodarone; arrhythmia; atrial fibrillation; lung transplant; mortality

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LUNG TRANSPLANTATION; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; TREATMENT OUTCOME;

AGED; AMIODARONE; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 78649942091     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.07.006     Document Type: Article

References (36)

1. T.D. Nielsen, T. Bahnson, and R.D. Davis Atrial fibrillation after pulmonary transplant Chest 126 2004 496 500
2. D.P. Mason, D.H. Marsh, and J.M. Alster Atrial fibrillation after lung transplantation: timing, risk factors, and treatment Ann Thorac Surg 84 2007 1878 1884
3. G.N. Holmbeck Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations J Pediatr Psychol 27 2002 87 96
4. Y. Sakr, C. Krauss, and A.C. Amaral Comparison of the performance of SAPS II, SAPS 3, APACHE II, and their customized prognostic models in a surgical intensive care unit Br J Anaesth 101 2008 798 803
5. M.I. Hertz, P. Aurora, and J.D. Christie Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation J Heart Lung Transplant 27 2008 937 942
6. W.D. Pitcher Amiodarone pulmonary toxicity Am J Med Sci 303 1992 206 212
7. J.D. Christie, L.B. Edwards, and P. Aurora Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heartlung transplantation report2008 J Heart Lung Transplant 27 2008 957 969
8. E.A. Martinez, E.B. Bass, and P. Zimetbaum Pharmacologic control of rhythm: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 suppl 2005 48S 55S
9. E.A. Martinez, A.E. Epstein, and E.B. Bass Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 suppl 2005 56S 60S
10. D. Bradley, L.L. Creswell, and C.W. Hogue Jr Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 suppl 2005 39S 47S
11. J.J. Heger, E.N. Prystowsky, and W.M. Jackman Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation N Engl J Med 305 1981 539 545
12. D.P. Zipes, E.N. Prystowsky, and J.J. Heger Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects J Am Coll Cardiol 3 1984 1059 1071
13. D. Roy, M. Talajic, and P. Dorian Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 2000 913 920
14. W.S. Aronow Atrial fibrillation Heart Dis 4 2002 91 101
15. S.M. Sobol, and L. Rakita Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug Circulation 65 1982 819 824
16. F.E. Marchlinski, T.S. Gansler, and H.L. Waxman Amiodarone pulmonary toxicity Ann Intern Med 97 1982 839 845
17. W.J. Martin Jr, and E.C. Rosenow III Amiodarone pulmonary toxicity Recognition and pathogenesis (Part 2) Chest 93 1988 1242 1248
18. W.J. Martin Jr, and E.C. Rosenow III Amiodarone pulmonary toxicity Recognition and pathogenesis (Part I) Chest 93 1988 1067 1075
19. W. Van Mieghem, L. Coolen, and I. Malysse Amiodarone and the development of ARDS after lung surgery Chest 105 1994 1642 1645
20. G.N. Kay, A.E. Epstein, and J.K. Kirklin Fatal postoperative amiodarone pulmonary toxicity Am J Cardiol 62 1988 490 492
21. A.J. Greenspon, G.A. Kidwell, and W. Hurley Amiodarone-related postoperative adult respiratory distress syndrome Circulation 84 suppl 1991 III-407 415
22. S. Kaushik, A. Hussain, and P. Clarke Acute pulmonary toxicity after low-dose amiodarone therapy Ann Thorac Surg 72 2001 1760 1761
23. P. Vassallo, and R.G. Trohman Prescribing amiodarone: an evidence-based review of clinical indications JAMA 298 2007 1312 1322
24. C.P. Reddy, and C.S. Kuo Effect of amiodarone on retrograde conduction and refractoriness of the His-Purkinje system in man Br Heart J 51 1984 648 653
25. A.E. Ratz Bravo, J. Drewe, and R.G. Schlienger Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature Crit Care Med 33 2005 128 134
26. S.M. Bagshaw, P.D. Galbraith, and L.B. Mitchell Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis Ann Thorac Surg 82 2006 1927 1937
27. H. Ashrafian, and P. Davey Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 120 2001 275 282
28. J.I. Kennedy, J.L. Myers, and V.J. Plumb Amiodarone pulmonary toxicity Clinical, radiologic, and pathologic correlations Arch Intern Med 147 1987 50 55
29. J.I. Kennedy Jr Clinical aspects of amiodarone pulmonary toxicity Clin Chest Med 11 1990 119 129
30. Fabiani I, Tacconi D, Grotti S, et al. Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema. J Cardiovasc Med (Hagerstown), (Epub ahead of print Nov 17, 2009).
31. T. Kimura, S. Kuramochi, and T. Katayama Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: diagnostic pitfall and new findings Pathol Int 58 2008 657 663
32. B. Coudert, F. Bailly, and J.N. Lombard Amiodarone pneumonitis Bronchoalveolar lavage findings in 15 patients and review of the literature Chest 102 1992 1005 1012
33. J.E. Kuhlman, C. Teigen, and H. Ren Amiodarone pulmonary toxicity: CT findings in symptomatic patients Radiology 177 1990 121 125
34. R.M. Siniakowicz, D. Narula, and B. Suster Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan J Cardiovasc Electrophysiol 12 2001 431 436
35. R.E. Dusman, M.S. Stanton, and W.M. Miles Clinical features of amiodarone-induced pulmonary toxicity Circulation 82 1990 51 59
36. R.C. King, O.A. Binns, and F. Rodriguez Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 2000 1681 1685